Cutler Group LP Athira Pharma, Inc. Put Options Transaction History

Cutler Group LP

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 04, 2022	SELL	$2.74 - $13.43 $22,742 - $111,469	-8,300 Reduced 24.78%	25,200 $112,000
Q4 2021 Jan 18, 2022	BUY	$9.17 - $16.39 $293,440 - $524,480	32,000 Added 2133.33%	33,500 $5,000
Q3 2021 Oct 26, 2021	SELL	$9.15 - $11.09 $13,725 - $16,635	-1,500 Reduced 50.0%	1,500 $4,000
Q2 2021 Jul 19, 2021	BUY	$10.24 - $20.87 $30,720 - $62,610	3,000 New	3,000 $6,000

16.9M

112K

68K

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $23.4M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.